Episode 60
Biotech Hangout
00:00
Billy Dunn Joins the Board of Prothena
Billy Dunn, former FDA Neuroscience Division head joining the Board of Prothena. Mike: The idea that someone who was running a FDA division and was reviewing and overseeing drug approvals, resigning after a long tenure career, I think raised a lot of people's eyebrows. On one hand, you would say, wow, that sounds amazing that a biotech would get expertise perspective and insight from someone on the Board of Directors to help you out from the FDA.
Transcript
Play full episode
